Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review

JUAN ALBERTO RUANO RUIZJUAN ALBERTO RUANO RUIZ2026-01-292026-01-29202110.1007/s13555-021-00517-92-s2.0-85104725689https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/33285DermatologyEfficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Reviewreview article